Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 58 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Co-Regulation Analysis of Domain-Specific Phosphosites Reveals Insights into the Phosphoregulation-Directed Functional Diversity of Nucleolin

  1. 1Centre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to Be University), Mangalore 575018, Karnataka, India

Abstract

Nucleolin (NCL) is a highly phosphorylated, multilocalized, pleiotropic nucleolar protein involved in chromatin organization, DNA damage response, the cell cycle, RNA metabolism, and ribosome biogenesis. A large-scale integration of publicly available human cellular phosphoproteome datasets led to the identification of 18 frequently detected/reported phosphosites across 1266 profiling and 507 differential datasets. Amidst various strategies currently being considered to target NCL in cancers, multi-domain distribution of these phosphosites differentially regulated across distinct cancers highlighted its plausible involvement in tumor-associated regulatory mechanisms. This demands the exploration of the potential kinases and interactors associated with these phosphorylation events. We performed a co-occurrence analysis to explore potential coordinated phosphorylation events among them and across other phosphoproteins. An integrative analysis of phosphosite-specific co-regulation, upstream kinases, and interaction networks was employed to explore potential phosphosite-specific signaling associations. Intriguingly, our analysis inferred the association of the predominant phosphosites within the acidic tract with chromatin organization and histone-related functions, whereas TPxKK motif phosphosites were linked to NCL localization, chromosome segregation, and nucleolar reorganization. Phosphosites in the RRM domain showed a potential association with RNA-binding proteins and metabolic pathways. Collectively, these findings suggest a domain-specific phosphosite-centric regulatory network of NCL, providing a valuable reference framework for future experimental studies and phosphosite-directed therapeutic strategies in cancers.

Related

  1. Global phosphoproteomics uncovers PANK2 phosphorylation sites and co-phosphoregulation networks
    Athira C. Rajeev, Althaf Mahin, Athira Perunelly Gopalakrishnan +2
    Results in ChemistryPeer-reviewedCC BYFull textPhysical chemistryDOAJ
  2. Systematic Phosphoproteomic Analysis of Co-Differentially Associated Phosphosites Within the WNK1 C-Terminal Disordered Region.
    Noreen A Khan, Amal Fahma, Athira Perunelly Gopalakrishnan +3
    Biotech (Basel (Switzerland))Peer-reviewedCC BYFull textPhysical chemistryEurope PMC
  3. Irradiation-Induced Defects and Functional Regulation in Metallic Materials: A Review
    Guang Hu, Tingting Zhou, Jing Tang +3
    NanomaterialsPeer-reviewedCC BY 4.0Materials & polymersCrossref
  4. Biostimulant Modulation of Soil Mycobiome Structure and Diversity and Amaranthus cruentus Growth Under Perfluorotetradecanoic Acid Stress
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral chemistryEurope PMC
  5. Umpolung of a Diazo Sulfonyl Fluoride Surrogate Expands Diversity-Oriented Clicking to Cyclopropanes
    Carol Hua, Christopher J. Smedley
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
BibTeX
@article{shaji2026coregulation,
  title = {{Co-Regulation Analysis of Domain-Specific Phosphosites Reveals Insights into the Phosphoregulation-Directed Functional Diversity of Nucleolin}},
  author = {Megha Shaji and Jaytha Thomas and Pathiyil Sajini Sekhar and Suhail Subair and Althaf Mahin and Leona Dcunha and Alimath Sambreena and Rajesh Raju and Sowmya Soman},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = oct,
  doi = {10.3390/ijms27209132},
  url = {https://www.mdpi.com/1422-0067/27/20/9132},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Co-Regulation Analysis of Domain-Specific Phosphosites Reveals Insights into the Phosphoregulation-Directed Functional Diversity of Nucleolin
AU  - Megha Shaji
AU  - Jaytha Thomas
AU  - Pathiyil Sajini Sekhar
AU  - Suhail Subair
AU  - Althaf Mahin
AU  - Leona Dcunha
AU  - Alimath Sambreena
AU  - Rajesh Raju
AU  - Sowmya Soman
PY  - 2026
DA  - 2026/10/15
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27209132
UR  - https://www.mdpi.com/1422-0067/27/20/9132
AB  - Nucleolin (NCL) is a highly phosphorylated, multilocalized, pleiotropic nucleolar protein involved in chromatin organization, DNA damage response, the cell cycle, RNA metabolism, and ribosome biogenesis. A large-scale integration of publicly available human cellular phosphoproteome datasets led to the identification of 18 frequently detected/reported phosphosites across 1266 profiling and 507 differential datasets. Amidst various strategies currently being considered to target NCL in cancers, multi-domain distribution of these phosphosites differentially regulated across distinct cancers highlighted its plausible involvement in tumor-associated regulatory mechanisms. This demands the exploration of the potential kinases and interactors associated with these phosphorylation events. We performed a co-occurrence analysis to explore potential coordinated phosphorylation events among them and across other phosphoproteins. An integrative analysis of phosphosite-specific co-regulation, upstream kinases, and interaction networks was employed to explore potential phosphosite-specific signaling associations. Intriguingly, our analysis inferred the association of the predominant phosphosites within the acidic tract with chromatin organization and histone-related functions, whereas TPxKK motif phosphosites were linked to NCL localization, chromosome segregation, and nucleolar reorganization. Phosphosites in the RRM domain showed a potential association with RNA-binding proteins and metabolic pathways. Collectively, these findings suggest a domain-specific phosphosite-centric regulatory network of NCL, providing a valuable reference framework for future experimental studies and phosphosite-directed therapeutic strategies in cancers.
SN  - 1422-0067
ER  -